Real-world data on emicizumab prophylaxis in the Milan cohort

Haemophilia. 2022 Sep;28(5):e141-e144. doi: 10.1111/hae.14630. Epub 2022 Jul 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / pharmacology
  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cohort Studies
  • Factor VIII / therapeutic use
  • Hemophilia A* / drug therapy
  • Humans

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • emicizumab
  • Factor VIII